Beacon Equity Research Featured Company: Generex Biotechnology Corp. (GNBT)
Generex Biotechnology is a drug research and development company whose expertise is finding innovative and commercialized ways to administer drugs throughout the human body. The company has developed a platform technology for the delivery of drugs via the oral cavity. To meet the demands of this type of drug administration, Generex developed its RapidMist™ device so that the drugs typically administered by injection can be absorbed into the body by the lining of the inner mouth. Combined with Generex’s proprietary liquid drug formulations, the company is able to achieve its goal of innovative drug administration. Generex’s flagship product, oral insulin…